International efforts, such as the EU’s Artificial Intelligence Act, have begun to address AI in healthcare through risk-based classifications, real-world testing and transparency mandates. In the U.S., however, AI regulation in healthcare remains fragmented and limited in scope.
Without clear guardrails, AI can reinforce systemic inequalities and create new forms of harm. The ACR will work with policymakers and stakeholders to ensure these powerful tools are used responsibly and ethically, especially when they directly impact patient care.
Looking Ahead
The ACR commended the NAIC for taking proactive steps to address the role of AI in insurance and expressed interest in ongoing collaboration to ensure that rheumatology patients are protected as these technologies continue to evolve. As a result, the ACR has been invited to the NAIC working group meetings. We look forward to providing ongoing feedback as the NAIC works on AI policy solutions and guardrails.
Joseph Cantrell, JD, is the director of state affairs and community relations for the ACR.